Morgan Ebert, Managing Editor

A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.

A new clinical trial has found that omalizumab (Xolair; Genetech, Novartis) is more effective than oral immunotherapy (OIT) in treating multi-food allergy in individuals with severe allergic reactions to small amounts of common food allergens.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

Early anxiety screening in pediatric primary care improves detection, outcomes, and access to mental health support starting at age 8.

If approved, SYD-101 would be the first and only pharmaceutical option for the treatment of progression of pediatric myopia in the United States.

The study, known as BRAVE-AA-PEDS, was sponsored by Eli Lilly and Company and involved 257 adolescents aged 12 to under 18 years.

The newest tapinarof results were presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting.

Lebrikizumab improves itch, sleep interference, and skin pain in atopic dermatitis patients previously treated with dupilumab, offering a new treatment option.

Cytomegalovirus (CMV) may worsen necrotizing enterocolitis (NEC) in premature infants, leading to severe intestinal damage.

Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] has now launched in the US for children aged 1 through 3 years with a confirmed diagnosis of peanut allergy.

A study finds air lead exposure increases infant mortality, linking emissions to low birthweight, SUID, and respiratory issues, urging stricter regulations.

The FDA has accepted PTC Therapeutics' NDA for vatiquinone, a potential treatment for Friedreich's ataxia, with a decision expected by August 19, 2025.

A study found that teens with obesity eat more later in the day than their peers, highlighting the role of the body’s circadian system in eating habits.

Most children with MIS-C recover within 6 months, with heart function and overall health improving significantly, according to a new study.

Shriners Children’s Boston warns patients and their parents about frostbite risks, offering tips on prevention, signs, and treatment to keep kids safe in extreme cold.

Parents’ screen habits influence kids' media use, with bedroom and mealtime screen time increasing exposure to mature content.

AI-assisted software improves clinicians' detection of congenital heart defects in prenatal ultrasounds, enhancing accuracy, confidence, and speed, according to a study presented at SMFM's Annual Pregnancy Meeting.

Swedish study highlights challenges in managing pain for preterm infants, revealing disparities in pain treatment and assessment across neonatal care.

UVA researchers identify key blood biomarkers linked to SIDS, paving the way for life-saving tests to detect and prevent this leading cause of death among infants.

HHS selects 15 more Medicare Part D drugs for price negotiation under the Inflation Reduction Act, aiming to lower costs for millions by 2027.

Kick off the new year with 8 parenting goals: update vaccines, build healthy habits, enjoy outdoor time, read daily, and prioritize mental health.

Revisit some of the most popular interviews with leading pediatric experts

Discover expert tips for safe and balanced tech use this holiday season with parental controls, privacy guidance, and social media insights.

Arcutis seeks FDA approval for roflumilast cream 0.05% (ZORVYE) to treat mild to moderate atopic dermatitis in children 2 to 5 years.

The FDA has approved Crenessity for managing classic CAH in patients 4 years and up, reducing steroid doses while controlling hormones, offering a safer treatment option.

Early HPV vaccination at age 9 boosts completion rates, reduces disparities, and enhances cancer prevention effort, according to a recent study from Nemours Children's Health.

Prenatal exposure to antiseizure medications like valproate and topiramate raises risks of ASD, ADHD, and ID in children; lamotrigine shows no increased risk.

Practicing gratitude boosts wellbeing, improves sleep, and reduces stress. Parents can foster it daily by modeling gratitude, helping others, and reflecting on positives.

HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.